VisiRose, a company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of ...
EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...
Confocal color imaging, green autofluorescence, and OCT are preferred for GA evaluation, each with unique benefits and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback